Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

Both companies have been struggling to meet massive demand for their products – Zepbound and Wegovy are both on the FDA's list of medicines in short supply – and a simpler-to-produce vial ...

That could be through habit-forming actions to help improve your daily movement, or by achieving your weight loss goals.

In obesity, it will compete with Novo Nordisk’s GLP-1 agonist Wegovy (semaglutide), which ... but has initially been made available in vials only as Lilly waits for EU approval of the KwikPen ...

Fearing federal agents asking to search a Chicago elementary school Friday morning were from Immigration and Customs ...

Pennsylvania-based pharmaceutical firm Provepharm Inc is voluntarily recalling vials of phenylephrine hydrochloride, which is used by surgeons to treat hypotension (low blood pressure ...

Veru said Monday that its investigational drug helped preserve lean mass in patients taking the obesity treatment Wegovy, though some experts were skeptical that the topline results were adequate ...

A major analysis of more than 1.2 million medical records has found popular diabetes and weight loss drugs, including Ozempic and Wegovy, may also reduce the risk of other health issues.

Clothing brands are among the businesses benefiting from the GLP-1 boom as users treat their slimmer selves Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...

COPENHAGEN--Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb. 22 next year, its first launch in Asia, the company said on Thursday, even as it struggles to keep ...

January 25, 2025 • A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts ...